Autoimmune Liver Diseases in Mexico: Clinical Characterization and Outcomes at a National Referral Center (2012–2022)
DOI:
https://doi.org/10.22516/25007440.1463Keywords:
Autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitisAbstract
Introduction: Autoimmune liver diseases, including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC), are uncommon, exhibit heterogeneous phenotypes, and remain poorly characterized in Latin American populations.
Objective: To describe the clinical and sociodemographic characteristics, as well as the outcomes, of patients with confirmed diagnoses of AIH, PBC, and PSC treated at a national referral center in Mexico between 2012 and 2022.
Materials and methods: A descriptive, cross-sectional observational study using secondary data sources was conducted. Adults with a confirmed diagnosis of autoimmune liver disease were included. Clinical, serological, and outcome variables were analyzed using descriptive statistics with Stata v.17.
Results: A total of 303 patients were analyzed, of whom 77.9% were women, with a mean age of 50 years. Diagnoses included AIH (78.9%), PBC (46.5%), and PSC (8.2%), with 98 cases of overlap syndromes (AIH–PBC: 93; AIH–PSC: 7). The most frequent comorbidities were overweight, hypothyroidism, dyslipidemia, and ulcerative colitis. Treatment response was higher in PBC (88.6%) and AIH (84.9%), whereas PSC showed a greater need for transplantation (68%) and recurrence (100%).
Conclusions: In this center, AIH was the most frequent entity, followed by PBC and PSC, with a considerable number of overlap syndromes, the most common being AIH–PBC. More favorable outcomes were observed in AIH and PBC, whereas PSC showed poorer clinical evolution. These findings provide relevant regional evidence and underscore the need for multicenter studies on autoimmune liver diseases in Latin America.
Downloads
References
Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut. 2021;70(10):1989-2003. https://doi.org/10.1136/gutjnl-2020-322362
Aguilar-Nájera O, Velasco-Zamora JA, Torre A. Diagnóstico y tratamiento de los síndromes de sobreposición de hepatitis autoinmune. Rev Gastroenterol Mex. 2015;80(2):150-9. https://doi.org/10.1016/j.rgmx.2015.04.001
Zhang W, De D, Mohammed KA, Munigala S, Chen G, Lai J, et al. New scoring classification for primary biliary cholangitis-autoimmune hepatitis overlap syndrome. Hepatol Commun. 2018;2(3):245-53. https://doi.org/10.1002/hep4.1148
Xi D, Lin H, Shah AA. Overview of autoimmune liver disease: Prevalence, risk factors, and role of autoantibodies. Clin Liver Dis (Hoboken). 2022;20(4):111-5. https://doi.org/10.1002/cld.1227
Selmi C, Generali E, Gershwin ME. Rheumatic Manifestations in Autoimmune Liver Disease. Rheumatic Disease Clinics of North America. 2018;44(1):65-87. https://doi.org/10.1016/j.rdc.2017.09.008
Fischer HP, Goltz D. Autoimmune Lebererkrankungen. Pathologe. 2020;41(5):444-56. https://doi.org/10.1007/s00292-020-00807-7
Lv T, Li M, Zeng N, Zhang J, Li S, Chen S, et al. Systematic review and meta‐analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population. J Gastroenterol Hepatol. 2019;34(10):1676-84. https://doi.org/10.1111/jgh.14746
Hahn JW, Yang HR, Moon JS, Chang JY, Lee K, Kim GA, et al. Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and meta-analysis. EClinicalMedicine. 2023;65:102280. https://doi.org/10.1016/j.eclinm.2023.102280
Mehta TI, Weissman S, Fung BM, Sotiriadis J, Lindor KD, Tabibian JH. Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta-analysis. Liver Int. 2021;41(10):2418-26. https://doi.org/10.1111/liv.15007
Trivedi PJ, Hirschfield GM, Adams DH, Vierling JM. Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts. Gastroenterology. 2024;166(6):995-1019. https://doi.org/10.1053/j.gastro.2024.01.049
Tanaka A, Mori M, Matsumoto K, Ohira H, Tazuma S, Takikawa H. Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan. Hepatology Research. 2019;49(8):881-9. https://doi.org/10.1111/hepr.13342
Núñez FP, Quera PR, Gomollón F. Colangitis esclerosante primaria y enfermedad inflamatoria intestinal: interrelación intestino-hígado. Gastroenterol Hepatol. 2019;42(5):316-25. https://doi.org/10.1016/j.gastrohep.2019.02.004
Bittermann T, Lewis JD, Levy C, Goldberg DS. Sociodemographic and geographic differences in the US epidemiology of autoimmune hepatitis with and without cirrhosis. Hepatology. 2023;77(2):367-78. https://doi.org/10.1002/hep.32653
Kim WR, Therneau TM, Wiesner RH, Poterucha JJ, Benson JT, Malinchoc M, et al. A Revised Natural History Model for Primary Sclerosing Cholangitis. Mayo Clin Proc. 2000;75(7):688-94. https://doi.org/10.4065/75.7.688
Sebode M, Weiler-Normann C, Liwinski T, Schramm C. Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance. Front Immunol. 2018;9:609. https://doi.org/10.3389/fimmu.2018.00609
Abdulkarim M, Zenouzi R, Sebode M, Schulz L, Quaas A, Lohse AW, et al. Sex differences in clinical presentation and prognosis in patients with primary biliary cholangitis. Scand J Gastroenterol. 2019;54(11):1391-6. https://doi.org/10.1080/00365521.2019.1683226
Kerkar N, Chan A. Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing Cholangitis or Overlap Syndrome. Clin Liver Dis. 2018;22(4):689-702. https://doi.org/10.1016/j.cld.2018.06.005
Liang H, Manne S, Shick J, Lissoos T, Dolin P. Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom. Medicine. 2017;96(24):e7116. https://doi.org/10.1097/MD.0000000000007116
Tischendorf JJW, Hecker H, Krüger M, Manns MP, Meier PN. Characterization, Outcome, and Prognosis in 273 Patients with Primary Sclerosing Cholangitis: A Single Center Study. Am J Gastroenterol. 2007;102(1):107-14. https://doi.org/10.1111/j.1572-0241.2006.00872.x
López Serrano P, Turnes Vázquez J. Autoimmune hepatitis, primary sclerosing cholangitis, and inflammatory bowel disease. Sequential overlap syndrome: a twist to the mosaic of autoimmunity. Rev Esp Enferm Dig. 2020;112(10):745-747. https://doi.org/10.17235/reed.2020.7512/2020
Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Primary sclerosing cholangitis. The Lancet. 2018;391(10139):2547-59. https://doi.org/10.1016/S0140-6736(18)30300-3
Kalas MA, Chavez L, Leon M, Taweesedt PT, Surani S. Abnormal liver enzymes: A review for clinicians. World J Hepatol. 2021;13(11):1688-98. https://doi.org/10.4254/wjh.v13.i11.1688
González-Huezo MS, Delgado-Ayala LY, Osorio-Núñez AL, Meléndez-Mercado C. Asociaciones autoinmunes en una cohorte mexicana con colangitis biliar primaria. Rev Gastroenterol Mex. 2019;84(2):130-5. https://doi.org/10.1016/j.rgmx.2018.03.008
Lleo A, Leung PSC, Hirschfield GM, Gershwin EM. The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review. Semin Liver Dis. 2020;40(01):034-48. https://doi.org/10.1055/s-0039-1697617
Tanaka A, Ma X, Takahashi A, Vierling JM. Primary biliary cholangitis. Lancet. 2024;404(10457):1053-66. https://doi.org/10.1016/S0140-6736(24)01303-5
Qin X, Jin Z. Progress and Perspectives in Overlapping Primary Biliary Cholangitis and Autoimmune Hepatitis: A Comprehensive Review. Journal of Gastrointestinal and Liver Diseases. 2025;34(2):241-9. https://doi.org/10.15403/jgld-6138
Cessa-Zanatta JC, Cortez-Hernández CA, Goyes D, Bonder A. Epidemiology and health care burden of autoimmune liver diseases in Mexico. Clin Liver Dis (Hoboken). 2024;23(1):e0089. https://doi.org/10.1097/CLD.0000000000000089
Couto CA, Villamil A, Terrabuio DRB, Tejada S, Castro-Narro G, Ridruejo E. Autoimmune liver diseases in Latin America: Current landscape and challenges. Hepatol Commun. 2025;10(1):e0830. https://doi.org/10.1097/HC9.0000000000000830
Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31(5):929-38. https://doi.org/10.1016/S0168-8278(99)80297-9
Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169-76. https://doi.org/10.1002/hep.22322
Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, et al. Autoimmune hepatitis. Nat Rev Dis Primers. 2018;4(1):18017. https://doi.org/10.1038/nrdp.2018.17
Culver EL, Bungay HK, Betts M, Forde C, Buchel O, Manganis C, et al. Prevalence and long‐term outcome of sub‐clinical primary sclerosing cholangitis in patients with ulcerative colitis. Liver International. 2020;40(11):2744-57. https://doi.org/10.1111/liv.14645
Richardson N, Ng STH, Wraith DC. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases. Front Immunol. 2020:11:1586. https://doi.org/10.3389/fimmu.2020.01586
Heneghan MA, Lohse AW. Update in clinical science: Autoimmune hepatitis. J Hepatol. 2025;82(5):926-937. https://doi.org/10.1016/j.jhep.2024.12.041
Shiffman ML. Autoimmune Hepatitis. Clin Liver Dis. 2024;28(1):1-14. https://doi.org/10.1016/j.cld.2023.06.002
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista colombiana de Gastroenterología

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.

| Article metrics | |
|---|---|
| Abstract views | 659 |
| Galley views | 352 |
| PDF Views | 329 |
| HTML views | 0 |
| Other views | 23 |














